Your browser doesn't support javascript.
loading
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Dourthe, Marie Emilie; Phulpin, Aurélie; Auperin, Anne; Bosq, Jacques; Couec, Marie-Laure; Dartigues, Peggy; Ducassou, Stéphane; Garnier, Nathalie; Haouy, Stéphanie; Leblanc, Thierry; Leruste, Amaury; Paillard, Catherine; Rigaud, Charlotte; Simonin, Mathieu; Patte, Catherine; Minard-Colin, Véronique.
Afiliação
  • Dourthe ME; Department of Pediatric Hematology and Immunology, Robert Debré University Hospital, AP-HP and University de Paris, Paris, France; Université de Paris, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology,
  • Phulpin A; Pediatric Oncology and Hematology Department, University Hospital of Nancy (CHRU Nancy), Nancy.
  • Auperin A; Service de Biostatistique et d'Epidémiologie, Gustave Roussy Cancer Campus, INSERM U1018, CESP, Université Paris-Sud, Université Paris-Saclay, Villejuif.
  • Bosq J; Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif.
  • Couec ML; Pediatric hematology and oncology department, University Hospital of Nantes, Nantes.
  • Dartigues P; Department of Biopathology, Morphology Unit, Gustave Roussy, Université Paris Saclay, Villejuif.
  • Ducassou S; Department of Pediatric Oncology and Haematology, University Hospital of Bordeaux, Bordeaux.
  • Garnier N; Institut d'Hématologie et d'Oncologie Pédiatrique, Hospices Civils de Lyon, Lyon.
  • Haouy S; Department of Pediatric Oncology and Haematology, University Hospital of Montpellier, Montpellier.
  • Leblanc T; Université de Paris, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris.
  • Leruste A; SIREDO Oncology Center, Institut Curie, PSL Research University, Paris.
  • Paillard C; Pediatric Hematology Oncology Department, University Hospital of Strasbourg, Strasbourg, France and INSERM UMR_S 1109.
  • Rigaud C; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif.
  • Simonin M; Université de Paris, Institut Necker-Enfants Malades (INEM), Institut national de la santé et de la recherche médicale (Inserm) U1151, and Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Paris, France; Pediatric Hematology Oncology Department, So
  • Patte C; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif.
  • Minard-Colin V; Departments of Pediatric and Adolescent Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; INSERM Unité 1015. veronique.minard@gustaveroussy.fr.
Haematologica ; 107(9): 2173-2182, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35236054
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article